The Discovery
The Unexpected Discovery
In 1981, a Canadian physiologist named Adolfo de Bold made a discovery that shocked the medical w...
Key moment
In 1981, a Canadian physiologist named Adolfo de Bold made a discovery that shocked the medical world.
In 1981, a Canadian physiologist named Adolfo de Bold made a discovery that shocked the medical world. He took tissue from the atria — the upper chambers of a rat's heart — ground it up, and injected the extract into other rats. Within minutes, the rats produced a massive amount of urine. Their blood pressure dropped. Something in heart tissue was controlling the kidneys and blood vessels. De Bold had proven something revolutionary: the heart wasn't just a pump. It was also a hormone-producing gland. Scientists had overlooked this for centuries because they assumed the heart's only job was to push blood around the body.
The Breakthrough
The Scientific Explosion
De Bold's discovery triggered a worldwide race to identify the mystery hormone.
Key moment
De Bold's discovery triggered a worldwide race to identify the mystery hormone.
De Bold's discovery triggered a worldwide race to identify the mystery hormone. Within three years, multiple teams isolated it. They called it atrial natriuretic peptide, or ANP, because it came from the atria and caused natriuresis — the release of sodium in urine. ANP was 28 amino acids long with a distinctive ring shape formed by a chemical bridge. Scientists quickly found that the heart released ANP whenever blood volume increased too much. It was nature's pressure release valve: when your blood pressure got too high, your heart released ANP to make your kidneys flush out water and salt, bringing pressure back down.
The Trials
From Laboratory to Patients
Clinical trials in the late 1980s and early 1990s tested synthetic ANP in patients with heart fai...
Key moment
ANP worked — it lowered blood pressure, reduced fluid overload, and helped the kidneys function better.
Clinical trials in the late 1980s and early 1990s tested synthetic ANP in patients with heart failure and high blood pressure. The results were mixed. ANP worked — it lowered blood pressure, reduced fluid overload, and helped the kidneys function better. But it had a problem: it broke down in the bloodstream within minutes. Patients needed continuous IV infusions. Several pharmaceutical companies tried to create longer-lasting versions. Nesiritide, a synthetic form of the related peptide BNP, eventually won FDA approval in 2001 for acute heart failure. But the quest for a stable, long-lasting ANP pill continues today.
The Crisis
The Biomarker Revolution
While ANP itself struggled as a drug, it became one of the most valuable diagnostic tools in card...
Key moment
While ANP itself struggled as a drug, it became one of the most valuable diagnostic tools in cardiology.
While ANP itself struggled as a drug, it became one of the most valuable diagnostic tools in cardiology. Doctors discovered that measuring BNP and its fragment NT-proBNP in blood could tell them whether a patient was in heart failure. Higher levels meant worse heart failure. The blood test was cheap, fast, and remarkably accurate. Emergency rooms around the world adopted it. When a patient came in short of breath, a quick BNP test could distinguish heart failure from lung disease within minutes. This single test changed emergency medicine forever, saving time, money, and lives by enabling faster, more accurate diagnosis.
The Legacy
Today and Tomorrow
Today, natriuretic peptide blood tests are performed hundreds of millions of times each year worl...
Key moment
Today, natriuretic peptide blood tests are performed hundreds of millions of times each year worldwide.
Today, natriuretic peptide blood tests are performed hundreds of millions of times each year worldwide. They guide treatment decisions for millions of heart failure patients. Researchers have also discovered that the natriuretic peptide system does far more than control blood pressure — it affects fat metabolism, bone growth, and even brain function. New drugs called neprilysin inhibitors (like sacubitril, combined with valsartan in the drug Entresto) work by preventing the body from breaking down ANP too quickly. This approach has become one of the most important advances in heart failure treatment in decades. De Bold's curious experiment with rat heart tissue launched an entire field of cardiovascular medicine.
Peptide history · 1981
Atrial Natriuretic Peptide
The hormone that proved the heart makes chemicals.
A 28-amino-acid hormone made by heart cells that controls blood pressure and fluid balance. Discovered in 1981, it revolutionized medicine by showing that the heart is an endocrine organ, not just a pump.
When this peptide was first identified
Compound classification
Current regulatory status
Main area of investigation
How this peptide is typically given
Molecular structure type
Dr. Adolfo José de Bold
University of Ottawa Heart Institute, Canada
Discovered ANP by injecting rat heart extracts and observing dramatic increases in urination and salt loss, proving the heart makes hormones
Dr. Henry Sonnenberg
University of Toronto, Canada
Co-discovered ANP with de Bold and documented the natriuretic (salt-releasing) response
Keiji Kangawa and Michio Matsuo
National Cardiovascular Center Research Institute, Osaka, Japan
Isolated and sequenced the complete ANP molecule, enabling production of carperitide
Dr. Paul Lewicki
University of Ottawa Heart Institute, Canada
Developed nesiritide (Natrecor), the first synthetic ANP for heart failure treatment in the US
15 milestones, 1980 – 2024.
- 1980Dr. de Bold observes hormone-like granules in atrial heart cells
- 1981De Bold publishes landmark paper showing rat heart extracts cause dramatic diuresis and natriuresis
- 1982Multiple research groups worldwide begin studying ANP, racing to isolate and sequence it
- 1984Keiji Kangawa's team in Japan isolates and sequences the complete 28-amino-acid ANP molecule
- 1988Researchers discover BNP, related natriuretic peptide from heart ventricles
- 1993Multiple Phase II clinical trials show synthetic ANP (nesiritide) improves heart failure symptoms
- 1995Japan approves carperitide (synthetic ANP) as first ANP medicine for acute heart failure
- 1999FDA approves nesiritide (Natrecor) for acute decompensated heart failure in the United States
- 2004BNP blood tests become standard diagnostic tool for heart failure worldwide
- 2006Studies show NT-proBNP testing improves early detection of heart disease in primary care
- 2010Combination of BNP/NT-proBNP testing integrated into official heart failure diagnosis guidelines
- 2015Researchers explore ANP role in preserving kidney function in heart failure patients
- 2020Studies investigate ANP's potential in treating sepsis and COVID-19 related complications
- 2023Research focuses on developing long-acting ANP analogs that work like oral medications
- 2024New clinical trials test ANP combined with other heart drugs for improved outcomes
ANP is a 28-amino-acid peptide hormone. Think of amino acids as LEGO blocks. Link 28 blocks in the right order and you get ANP. Your heart's atrial cells store ANP in tiny packets called granules. When blood volume or pressure rises, stretch sensors in the heart walls activate. The heart releases ANP into your bloodstream. ANP travels to the kidneys and blood vessels, delivering its message: 'Release water and salt. Relax the blood vessel walls.' This happens within minutes, making ANP one of your body's fastest blood pressure controllers.
Molecular structure
- Structure
- 28 amino acid peptide chain
- Molecular Weight
- Approximately 3,075 Daltons
- Primary Source
- Atrial cardiomyocytes (heart muscle cells in upper chambers)
- Precursor
- proANP, a 126-amino-acid prohormone cleaved to release active ANP
Diagnosed with heart failure, many detected early through BNP blood tests
The simple building-block chain that revolutionized cardiac medicine
Changed fundamental understanding that organs can both pump and make hormones
ANP has been used successfully in acute heart failure treatment worldwide
Real stories, real lives
Marcus, 67-year-old retired teacher
Marcus began getting short of breath climbing stairs three years ago. His doctor ordered a BNP blood test—simple and quick. The elevated results suggested heart failure. Marcus went to the hospital for an echocardiogram, which confirmed his heart wasn't pumping as well as it should. Now he takes heart medications and his BNP level stays normal. Marcus says: 'That blood test caught my problem early. Without it, I probably would have gotten much sicker.' He hikes again and plays with his grandkids without gasping.
Sarah, 51-year-old marathon runner
Sarah noticed unusual fatigue during training. Her resting heart rate was oddly fast. She got a BNP blood test to rule out heart problems before a big race. Her test showed elevated levels, shocking her. Further testing revealed she had a heart condition she didn't know about. She underwent treatment before it became serious. Sarah says: 'I never thought a simple blood test would save my running career. The ANP hormone helped doctors find something I couldn't feel.' She now races at a lower intensity but remains healthy and active.
The future of Natriuretic Peptide (ANP)
- Oral ANP MedicationsResearch Stage
Scientists are engineering ANP versions that survive stomach acid so patients can take pills instead of injections. This could make ANP therapy available to millions more people.
- Preventive ANP TherapyResearch Stage
Research explores whether boosting natural ANP early might prevent heart disease development. This could help people with risk factors stay healthy longer.
- Sepsis and Infection TreatmentResearch Stage
Recent studies show ANP might protect organs when severe infections cause dangerous inflammation. Trials are testing ANP in septic shock patients.
Be inspired
The story of Natriuretic Peptide (ANP) is ultimately about the relentless pursuit of better medicine for humanity.
Continue the legacy. The next breakthrough could be yours.